Prostate specimen reevaluation in patients with organ confined prostate cancer and postoperative biological recurrence

Journal of Urology

Volumn 155, Issue 6, 1996, Pages 1981-1982

  Ravery, Vincent ^b   De La Taille, Alexandre ^b   Toublanc, Marianne ^b   Boccon Gibod, Liliane ^b   Hermieu, Jean François ^b   Delmas, Vincent ^b   Boccon Gibod, Laurent ^b  

^a ARMAND TROUSSEAU HOSPITAL   (France)

^b NONE

Author keywords

pathology; prostate specific antigen; prostatectomy; prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER STAGING; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; TUMOR VOLUME;

EID: 0029864131     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)66068-3     Document Type: Article

References (10)

1. Cooner, W. H., Mosley, B. R., Rutherford, C. L., Jr., Beard, J. H., Pond, H. S., Terry, W. J., Igel, T. C. and Kidd, D. D.: Prostate cancer detection in a clinical urological practice by ultrasound, digital rectal examination and prostate specific antigen. J. Urol., 143: 1146, 1990.
2. Lange, P. H., Ercole, C. J., Lightner, D. J., Fraley, E. E. and Vessella, R.: The value of serum prostate specific antigen determinations before and after radical prostatectomy. J. Urol., 141: 873, 1989.
3. Hudson, M. A., Bahnson, R. R. and Catalona, W. J.: Clinical use of prostate specific antigen in patients with prostate cancer. J. Urol., 142: 1011, 1989.
4. Humphrey, P. A., Frazier, H. A., Vollmer, R. T. and Paulson, D. F.: Stratification of pathologic features in radical prostatectomy specimens that are predictive of elevated initial postoperative serum prostate-specific antigen levels. Cancer, 71: 1821, 1993.
5. Stamey, T. A., McNeal, J. E., Freiha, F. S. and Redwine, E.: Morphometric and clinical studies on 68 consecutive radical prostatectomies. J. Urol., 139: 1235, 1988.
6. Epstein, J. I., Pizov, G. and Walsh, P. C.: Correlation of pathologic findings with progression after radical retropubic prostatectomy. Cancer, 71: 3582, 1993.
7. Stein, A., deKernion, J. B., Smith, R. B., Dorey, F. and Patel, H.: Prostate specific antigen levels after radical prostatectomy in patients with organ confined and locally extensive prostate cancer. J. Urol., part 2, 147: 942, 1992.
8. Frazier, H. A., Robertson, J. E., Humphrey, P. A. and Paulson, D. F.: Is prostate specific antigen of clinical importance in evaluating outcome after radical prostatectomy. J. Urol., 149: 516, 1993.
9. Lightner, D. J., Lange, P. H., Reddy, P. K. and Moore, L.: Prostate specific antigen and local recurrence after radical prostatectomy. J. Urol., 144: 921, 1990.
10. Ravery, V., Boccon-Gibod, L. A., Dauge-Geffroy, M. C., Billebaud, T., Delmas, V., Meulemans, A., Toublanc, M. and Boccon-Gibod, L.: Systematic biopsies accurately predict extracapsular extension of prostate cancer and persistent/recurrent detectable PSA after radical prostatectomy. Urology, 44: 371, 1994.